Sanofi to buy Genzyme for $20.1 billion | india | Hindustan Times
Today in New Delhi, India
Aug 22, 2017-Tuesday
-°C
New Delhi
  • Humidity
    -
  • Wind
    -

Sanofi to buy Genzyme for $20.1 billion

French drug maker Sanofi-Aventis SA on Wednesday agreed to buy Genzyme Corp with a sweetened $20.1 billion cash offer, plus payments tied to the success of the US biotech group’s drugs, the companies said on Wednesday.

india Updated: Feb 17, 2011 00:51 IST

French drug maker Sanofi-Aventis SA on Wednesday agreed to buy Genzyme Corp with a sweetened $20.1 billion cash offer, plus payments tied to the success of the US biotech group’s drugs, the companies said on Wednesday.

Sanofi will pay $74 a share in cash and offer a tradable contingent value right, or CVR, whose value will depend on Genzyme’s experimental multiple sclerosis drug Lemtrada and production of two other medicines.

The deal’s announcemen marks the second-biggest in biotech history and will help Sanofi offset declining revenue from drugs that have lost, or are set to lose, patent protection.